{'fraction_non_alphanumeric': 0.02847380410022779, 'fraction_numerical': 0.01879271070615034, 'mean_word_length': 4.8762541806020065, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[EVE, a regional campaign for the screening of cervical cancer. Organization, 7-years results and perspectives].

OBJECTIVE
Based on the 7-years results, assess the interest of organised cervical cancer screening on regional level (the EVE campaign). ORGANISATION AND METHOD: The screening relied on existing medical structures. The centralised data collection, with data from the cyto-pathology laboratories assessed the quality of screening and the participation of the women to the follow-up of abnormal smears. The campaign run by a local women's rights association and sponsored by National educational and health information funds (FNPEIS) and the local councils.


RESULTS
To date, 814 649 smears in the Bas-Rhin and 62 227 in the Haut-Rhin have been collected. After 3 years, 72% of women aged 25 to 64 in the year 1997, in the Bas-Rhin, had had at least one smear, and 82% after 5 years. Inadequate smears represented less than 1% of all smears of the region. Pathological smears represented around 4% of the total and benefited from strict monitoring which could be improved. However this could be improved on since only 75% of women in whom a low-grade lesion was suspected underwent a second examination within the year that followed. The rate was on 80% for those with suspected high-grade lesions. Reminders made by the EVE association, in agreement with practitioners, permitted postponed follow-up and improved screening coverage.


CONCLUSION
The EVE programme clearly shows that organized screening is feasible in France because the results obtained are satisfactory in terms of screening coverage and quality of smears. Centralised data collection permits detection of possible weak points and contributes to the improvement in efficacy.